Published in JAMA on April 23, 2014
Predictors for Prehospital Delay in Stroke Treatment | NCT03759691
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Screening with MRI for Accurate and Rapid Stroke Treatment: SMART. Neurology (2015) 1.66
Implementation of an institution-wide acute stroke algorithm: Improving stroke quality metrics. Surg Neurol Int (2016) 1.40
Immune interventions in stroke. Nat Rev Neurol (2015) 0.94
Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse Models. Gastroenterology (2015) 0.91
Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates? Neurol Clin Pract (2015) 0.89
Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system. Lancet (2015) 0.84
National implementation of acute stroke care centers in the Veterans Health Administration (VHA): formative evaluation of the field response. J Gen Intern Med (2014) 0.82
Factors Associated with In-Hospital Delay in Intravenous Thrombolysis for Acute Ischemic Stroke: Lessons from China. PLoS One (2015) 0.81
24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator. J Stroke Cerebrovasc Dis (2016) 0.81
Evolving use of seizure medications after intracerebral hemorrhage: A multicenter study. Neurology (2016) 0.80
Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry. Neurology (2016) 0.80
Sex Disparities in Ischemic Stroke Care: FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities). Stroke (2016) 0.79
The Influence of Language Discordance Between Patient and Physician on Time-to-Thrombolysis in Acute Ischemic Stroke. Neurohospitalist (2016) 0.79
Generalization of the Right Acute Stroke Prevention Strategies in Reducing in-Hospital Delays. PLoS One (2016) 0.79
Chronic Stroke Outcome Measures for Motor Function Intervention Trials: Expert Panel Recommendations. Circ Cardiovasc Qual Outcomes (2015) 0.78
Stroke code improves intravenous thrombolysis administration in acute ischemic stroke. PLoS One (2014) 0.78
The effect of telestroke systems among neighboring hospitals: more and better? The Madrid Telestroke Project. J Neurol (2014) 0.78
Association between i.v. thrombolysis volume and door-to-needle times in acute ischemic stroke. J Neurol (2016) 0.77
tPA for stroke: important progress in achieving faster treatment. JAMA (2014) 0.77
Endovascular Treatment for Acute Ischemic Stroke: Updates and Future Implications. Interv Neurol (2015) 0.77
Pathogenic mechanisms following ischemic stroke. Neurol Sci (2017) 0.76
Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors. Cerebrovasc Dis Extra (2015) 0.76
Multidisciplinary Approach to Decrease In-Hospital Delay for Stroke Thrombolysis. J Stroke (2017) 0.75
Predictors of diagnostic neuroimaging delays among adults presenting with symptoms suggestive of acute stroke in Ontario: a prospective cohort study. CMAJ Open (2016) 0.75
Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care. Circ Cardiovasc Qual Outcomes (2017) 0.75
A low-cost, tablet-based option for prehospital neurologic assessment: The iTREAT Study. Neurology (2016) 0.75
Stroke thrombolysis given by emergency physicians cuts in-hospital delays significantly immediately after implementing a new treatment protocol. Scand J Trauma Resusc Emerg Med (2016) 0.75
Imaging of prehospital stroke therapeutics. Expert Rev Cardiovasc Ther (2015) 0.75
Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke. PLoS One (2016) 0.75
Acute stroke alert activation, emergency service use, and reperfusion therapy in Sweden. Brain Behav (2017) 0.75
Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13. Sci Rep (2016) 0.75
Thrombolysis in Stroke within 30 Minutes: Results of the Acute Brain Care Intervention Study. PLoS One (2016) 0.75
Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery. Brain Behav (2017) 0.75
Propensity score weighting for a continuous exposure with multilevel data. Health Serv Outcomes Res Methodol (2016) 0.75
Monte Carlo Simulation Modeling of a Regional Stroke Team's Use of Telemedicine. Acad Emerg Med (2015) 0.75
Acute Stroke: Current Evidence-based Recommendations for Prehospital Care. West J Emerg Med (2016) 0.75
The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke. Stroke Vasc Neurol (2017) 0.75
The Door to Needle Time Metric Can Be Achieved via Telestroke. Neurohospitalist (2017) 0.75
Disparities and Trends in Door-to-Needle Time: The FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities). Stroke (2017) 0.75
Impact of an Expanded Hospital Recognition Program for Stroke Quality of Care. J Am Heart Assoc (2017) 0.75
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents. J Stroke (2017) 0.75
The American Heart Association's Get With the Guidelines (GWTG)-Stroke development and impact on stroke care. Stroke Vasc Neurol (2017) 0.75
A resident boot camp for reducing door-to-needle times at academic medical centers. Neurol Clin Pract (2017) 0.75
Stroke Hospital Characteristics in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study. South Med J (2017) 0.75
Review of acute ischaemic stroke in Pakistan: progress in management and future perspectives. Stroke Vasc Neurol (2017) 0.75
New standardized nursing cooperation workflow to reduce stroke thrombolysis delays in patients with acute ischemic stroke. Neuropsychiatr Dis Treat (2017) 0.75
Recent advances in the management of acute ischemic stroke. F1000Res (2017) 0.75
Influence of a combined CT/C-arm system on periprocedural workflow and procedure times in mechanical thrombectomy. Eur Radiol (2017) 0.75
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis. J Am Coll Cardiol (2015) 2.82
Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation. JAMA Intern Med (2015) 1.46
Association of Arterial Pulse Pressure With Long-Term Clinical Outcomes in Patients With Heart Failure. JACC Heart Fail (2015) 1.39
Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry. JAMA Neurol (2015) 0.91
Drug delivering technology for endovascular management of infrainguinal peripheral artery disease. JACC Cardiovasc Interv (2014) 0.81
Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. JAMA Neurol (2016) 0.80
Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry. JAMA Cardiol (2016) 0.76
Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development. Alzheimers Dement (N Y) (2016) 0.75
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting. J Am Coll Cardiol (2017) 0.75
Regression to the Mean in SYMPLICITY HTN-3: Implications for Design and Reporting of Future Trials. J Am Coll Cardiol (2016) 0.75
Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke. Int J Cardiol (2020) 0.75
New insights into cerebral small vessel disease and vascular cognitive impairment from MRI. Curr Opin Neurol (2017) 0.75
Sex differences in the impact of acute stroke treatment in a population-based study: a sex-specific propensity score approach. Ann Epidemiol (2017) 0.75
Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's disease. Alzheimers Dement (N Y) (2017) 0.75